| 注册
首页|期刊导航|中国医学伦理学|精神类药物临床试验中受试者权益保障的伦理思考

精神类药物临床试验中受试者权益保障的伦理思考

廖芸佳 古津贤

中国医学伦理学2017,Vol.30Issue(8):994-997,4.
中国医学伦理学2017,Vol.30Issue(8):994-997,4.DOI:10.12026/j.issn.1001-8565.2017.08.17

精神类药物临床试验中受试者权益保障的伦理思考

Ethical Thinking on Subjects' Rights and Interests Protection in Psychiatric Drug Clinical Trials

廖芸佳 1古津贤1

作者信息

  • 1. 天津医科大学医学人文学院,天津300070
  • 折叠

摘要

Abstract

Due to the special nature of mental patients and psychiatric drugs,we have to recruit mental patients as subjects in psychiatric drug clinical trials.In the process of the experiments,there exist ethical problems.For example,the right of life and health is threatened,the informed consent is insufficient,and the privacy of the subjects cannot be protected.This paper ethically analyzed them,explored the ethical principles,and proposed some objective and feasible countermeasures,in order to promote the development of medicine and health care and protect the rights of mental patients in psychotropic drug clinical trials.

关键词

精神类药物/临床试验/受试者/权益保障

Key words

Psychiatric Drug/Clinical Trial/Subjects/Rights and Interests Protection

分类

医药卫生

引用本文复制引用

廖芸佳,古津贤..精神类药物临床试验中受试者权益保障的伦理思考[J].中国医学伦理学,2017,30(8):994-997,4.

中国医学伦理学

OACSTPCD

1001-8565

访问量0
|
下载量0
段落导航相关论文